Related Experiment Videos
Severe amitriptyline overdose: relationship between toxicokinetics and toxicodynamics.
B A Hultén1, A Heath, K Knudsen
1Department of Anaesthesia and Intensive Care, Lillhagens Hospital, Gothenburg, Sweden.
Journal of Toxicology. Clinical Toxicology
|January 1, 1992
Summary
Predicting outcomes in severe amitriptyline poisoning is challenging due to variable drug and metabolite concentrations. Individual patient factors significantly influence clinical features and toxicokinetics, making single measurements unreliable for prognosis.
Area of Science:
- Pharmacology
- Clinical Toxicology
Background:
- Amitriptyline is a tricyclic antidepressant with a narrow therapeutic index.
- Severe poisoning can lead to life-threatening complications.
Purpose of the Study:
- To investigate the clinical features and toxicokinetics of amitriptyline in severe poisoning.
- To explore correlations between drug/metabolite levels and clinical outcomes.
Main Methods:
- Studied nine patients with severe amitriptyline poisoning.
- Measured amitriptyline and its metabolites in plasma, red blood cells, and cerebrospinal fluid.
- Monitored clinical features including QRS duration, level of consciousness, and complications.
Main Results:
- QRS duration correlated with plasma/RBC nortriptyline and unbound amitriptyline.
- Level of consciousness correlated with plasma/unbound amitriptyline and RBC amitriptyline.
- No correlation found between coma grade/QRS duration and cerebrospinal fluid concentrations.
- Hydroxymetabolite levels did not correlate with QRS duration or coma grade.
- Shorter amitriptyline beta half-life observed in patients with high hydroxymetabolite levels.
Conclusions:
- Individual variability in amitriptyline and metabolite concentrations hinders outcome prediction.
- Clinical presentation and toxicokinetics are complex and multifactorial in severe poisoning.